The safety of intrauterine devices among young women: a systematic review

Contraception

Volumn 95, Issue 1, 2017, Pages 17-39

  Jatlaoui, Tara C ^a   Riley, Halley E M ^a   Curtis, Kathryn M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Adolescents; Intrauterine device; IUD; LARC; Teens; Young women

Indexed keywords

COPPER; ETONOGESTREL; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; CONTRACEPTIVE AGENT; DESOGESTREL;

ADVERSE OUTCOME; ANEMIA; CINAHL; COCHRANE LIBRARY; COPPER INTRAUTERINE DEVICE; DEVICE INFECTION; DEVICE SAFETY; EMBASE; FEMALE; GROUPS BY AGE; HEALTH INSURANCE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MEDLINE; MULTICENTER STUDY (TOPIC); ORAL CONTRACEPTION; PELVIC INFLAMMATORY DISEASE; PERFORATION; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; UTERUS BLEEDING; ADOLESCENT; ADVERSE EFFECTS; CONTRACEPTION; PROCEDURES; RISK ASSESSMENT; UNPLANNED PREGNANCY; YOUNG ADULT;

ADOLESCENT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; FEMALE; HUMANS; INTRAUTERINE DEVICE EXPULSION; INTRAUTERINE DEVICES, COPPER; LEVONORGESTREL; PREGNANCY; PREGNANCY, UNPLANNED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; YOUNG ADULT;

EID: 85006004114     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2016.10.006     Document Type: Review

References (28)

1. [1] Kavanaugh, M.L., Frohwirth, L., Jerman, J., Popkin, R., Ethier, K., Long-acting reversible contraception for adolescents and young adults: patient and provider perspectives. J Pediatr Adolesc Gynecol 26 (2013), 86–95.
2. [2] Workowski, K.A., Bolan, G.A., Centers for Disease C, Prevention, Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64 (2015), 1–137.
3. [3] Mohllajee, A.P., Curtis, K.M., Peterson, H.B., Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception 73 (2006), 145–153.
4. [4] Grimes, D.A., Intrauterine device and upper-genital-tract infection. Lancet 356 (2000), 1013–1019.
5. [5] Hubacher, D., Lara-Ricalde, R., Taylor, D.J., Guerra-Infante, F., Guzman-Rodriguez, R., Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 345 (2001), 561–567.
6. [6] Hatcher, R.A.T.J., Nelson, A.L., Cates, W., Kowal, D., Policar, M.S., Contraceptive technology. 20 ed., 2011, Ardent Media, Inc., Atlanta, GA.
7. [7] Medical eligibility criteria for contraceptive use. 5th ed., 2015 [Geneva].
8. [8] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 (2009), 264–269.
9. [9] Harris, R.P., Helfand, M., Woolf, S.H., Lohr, K.N., Mulrow, C.D., Teutsch, S.M., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 (2001), 21–35.
10. [10] Albert, A., Carrasco, F., Duenas, J.L., Navarro, J., Analysis of minor complications in copper IUD wearers. Clin Invest Ginecol Obstet 10 (1983), 16–22.
11. [11] Alton, T.M., Brock, G.N., Yang, D., Wilking, D.A., Hertweck, S.P., Loveless, M.B., Retrospective review of intrauterine device in adolescent and young women. J Pediatr Adolesc Gynecol 25 (2012), 195–200.
12. [12] Aoun, J., Dines, V.A., Stovall, D.W., Mete, M., Nelson, C.B., Gomez-Lobo, V., Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol 123 (2014), 585–592.
13. [13] Behringer, T., Reeves, M.F., Rossiter, B., Chen, B.A., Schwarz, E.B., Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women. Contraception 84 (2011), e5–e10.
14. [14] Berenson, A.B., Tan, A., Hirth, J.M., Wilkinson, G.S., Complications and continuation of intrauterine device use among commercially insured teenagers. Obstet Gynecol 121 (2013), 951–958.
15. [15] Berenson, A.B., Tan, A., Hirth, J.M., Complications and continuation rates associated with 2 types of long-acting contraception. Am J Obstet Gynecol 212 (2015), 761.e1–761.e8.
16. [16] Luukkainen, T., Allonen, H., Nielsen, N.C., Nygren, K.G., Pyorala, T., Five years’ experience of intrauterine contraception with the Nova-T and the Copper-T-200. Am J Obstet Gynecol 147 (1983), 885–892.
17. [17] Allonen, H., Luukkainen, T., Nielsen, N.C., Nygren, K.G., Pyorala, T., Factors affecting the clinical performance of Nova T and Copper T 200. Obstet Gynecol 64 (1984), 524–529.
18. [18] Nygren, K.G., Nielsen, N.C., Pyorala, T., Allonen, H., Luukkainen, T., Intrauterine contraception with Nova-T and Copper-T-200 during three years. Contraception 24 (1981), 529–542.
19. [19] Madden, T., McNicholas, C., Zhao, Q., Secura, G.M., Eisenberg, D.L., Peipert, J.F., Association of age and parity with intrauterine device expulsion. Obstet Gynecol 124 (2014), 718–726.
20. [20] Rasheed, S.M., Abdelmonem, A.M., Complications among adolescents using copper intrauterine contraceptive devices. Int J Gynaecol Obstet 115 (2011), 269–272.
21. [21] Ravi, A., Prine, L., Waltermaurer, E., Miller, N., Rubin, S.E., Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network. J Am Board Fam Med 27 (2014), 822–830.
22. [22] Skajaa, K., Dorup, I., Skajaa, T., Complications caused by intrauterine contraceptive devices. Ugeskr Laeger 152 (1990), 3002–3006.
23. [23] Suhonen, S., Haukkamaa, M., Jakobsson, T., Rauramo, I., Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 69 (2004), 407–412.
24. [24] Teal, S.B., Romer, S.E., Goldthwaite, L.M., Peters, M.G., Kaplan, D.W., Sheeder, J., Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications. Am J Obstet Gynecol, 2015, 515.e1–515.e5.
25. [25] Zhang, J., Feldblum, P.J., Chi, I.C., Farr, M.G., Risk factors for copper T IUD expulsion: an epidemiologic analysis. Contraception 46 (1992), 427–433.
26. [26] Luukkainen, T., Nielsen, N.C., Nygren, K.G., Pyorala, T., Nulliparous women, IUD and pelvic infection. Ann Clin Res 11 (1979), 121–124.
27. [27] Allonen, H., Luukkainen, T., Nielsen, N.C., Nygren, K.G., Pyorala, T., Two-year rates for Nova T and Copper T in a comparative study. Contraception 21 (1980), 321–334.
28. [28] Trussell, J., Contraceptive failure in the United States. Contraception 83 (2011), 397–404.